Chemical formula: C₁₆H₁₈ClN₃S Molecular mass: 319.85 g/mol PubChem compound: 6099
In vivo, in low concentration, methylthioninium chloride speeds up the conversion of methaemoglobin to haemoglobin. Methylthioninium chloride has been observed to stain tissues selectively.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V03AB17 | Methylthioninium chloride | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes |
| V04CG05 | Methylthioninium chloride | V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CG Tests for gastric secretion |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| METHYLTHIONINIUM CHLORIDE PROVEBLUE Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Methylthioninium chloride is an active ingredient of these brands:
United States (US)Austria (AT)
Brazil (BR)Croatia (HR)
France (FR)
Ireland (IE)
Italy (IT)
Lithuania (LT)
New Zealand (NZ)Poland (PL)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
